M. Byron Kneller

Identification and Functional Characterization of a New CYP2C9 Variant (CYP2C9*5) Expressed among African Americans

Leslie J. Dickmann, Allan E. Rettie, M. Byron Kneller et al. · Molecular Pharmacology · 2001 · 250 citations

(+)-N-3-Benzyl-Nirvanol and (−)-N-3-Benzyl-Phenobarbital: New Potent and Selective in Vitro Inhibitors of CYP2C19

Hisashi Suzuki, M. Byron Kneller, Robert L. Haining et al. · Drug Metabolism and Disposition · 2002 · 94 citations

Active-site characteristics of CYP2C19 and CYP2C9 probed with hydantoin and barbiturate inhibitors

Hisashi Suzuki, M. Byron Kneller, Dan A. Rock et al. · Archives of Biochemistry and Biophysics · 2004 · 44 citations

Molecular Pharmacology, Medicinal Chemistry, Drug Analysis +14

Purification and Characterization of Hexahistidine-Tagged Cyclohexanone Monooxygenase Expressed in Saccharomyces cerevisiae and Escherichia coli

Matthew James Cheesman, M. Byron Kneller, Edward J. Kelly et al. · Protein Expression and Purification · 2001 · 34 citations

Biosynthesis, Cellular Enzymology, Biochemistry +11

Covalent Heme Binding to CYP4B1 via Glu310 and a Carbocation Porphyrin Intermediate

Yi-Min Zheng, Brian R. Baer, M. Byron Kneller et al. · Biochemistry · 2003 · 33 citations